227 related articles for article (PubMed ID: 36100925)
1. Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.
Xu S; Coleman RL; Wan Q; Gu Y; Meng G; Song K; Shi Z; Xie Q; Tuomilehto J; Holman RR; Niu K; Tong N
Cardiovasc Diabetol; 2022 Sep; 21(1):182. PubMed ID: 36100925
[TBL] [Abstract][Full Text] [Related]
2. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
3. Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance.
Xu S; Scott CAB; Coleman RL; Tuomilehto J; Holman RR
J Diabetes; 2021 Oct; 13(10):817-826. PubMed ID: 33665904
[TBL] [Abstract][Full Text] [Related]
4. Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study.
Abbasi A; Peelen LM; Corpeleijn E; van der Schouw YT; Stolk RP; Spijkerman AM; van der A DL; Moons KG; Navis G; Bakker SJ; Beulens JW
BMJ; 2012 Sep; 345():e5900. PubMed ID: 22990994
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK.
Wan C; Read S; Wu H; Lu S; Zhang X; Wild SH; Liu Y
Glob Heart; 2022; 17(1):46. PubMed ID: 36051323
[TBL] [Abstract][Full Text] [Related]
6. External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: the PREVEND study.
Abbasi A; Corpeleijn E; Peelen LM; Gansevoort RT; de Jong PE; Gans RO; Rathmann W; Kowall B; Meisinger C; Hillege HL; Stolk RP; Navis G; Beulens JW; Bakker SJ
Eur J Epidemiol; 2012 Jan; 27(1):47-52. PubMed ID: 22215562
[TBL] [Abstract][Full Text] [Related]
7. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of the CHIME simulation model to assess lifetime health outcomes of prediabetes and type 2 diabetes in Chinese populations: A modeling study.
Quan J; Ng CS; Kwok HHY; Zhang A; Yuen YH; Choi CH; Siu SC; Tang SY; Wat NM; Woo J; Eggleston K; Leung GM
PLoS Med; 2021 Jun; 18(6):e1003692. PubMed ID: 34166382
[TBL] [Abstract][Full Text] [Related]
9. External Validation of a Tool Predicting 7-Year Risk of Developing Cardiovascular Disease, Type 2 Diabetes or Chronic Kidney Disease.
Rauh SP; Rutters F; van der Heijden AAWA; Luimes T; Alssema M; Heymans MW; Magliano DJ; Shaw JE; Beulens JW; Dekker JM
J Gen Intern Med; 2018 Feb; 33(2):182-188. PubMed ID: 29204973
[TBL] [Abstract][Full Text] [Related]
10. External validation of prognostic models for chronic kidney disease among type 2 diabetes.
Saputro SA; Pattanateepapon A; Pattanaprateep O; Aekplakorn W; McKay GJ; Attia J; Thakkinstian A
J Nephrol; 2022 Jul; 35(6):1637-1653. PubMed ID: 34997924
[TBL] [Abstract][Full Text] [Related]
11. Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data.
Coles B; Khunti K; Booth S; Zaccardi F; Davies MJ; Gray LJ
BMJ Open; 2020 Oct; 10(10):e037937. PubMed ID: 33099496
[TBL] [Abstract][Full Text] [Related]
12. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
[TBL] [Abstract][Full Text] [Related]
13. Development and External Validation of a Multivariable Prediction Model to Identify Nondiabetic Hyperglycemia and Undiagnosed Type 2 Diabetes: Diabetes Risk Assessment in Dentistry Score (DDS).
Yonel Z; Kocher T; Chapple ILC; Dietrich T; Völzke H; Nauck M; Collins G; Gray LJ; Holtfreter B
J Dent Res; 2023 Feb; 102(2):170-177. PubMed ID: 36254392
[TBL] [Abstract][Full Text] [Related]
14. [Applications of the NDR and DIAL models for risk prediction on cardiovascular disease in patients with type 2 diabetes in Ningbo].
Li QQ; Liang JY; Wang JM; Shen P; Sun YX; Chen Q; Wu JG; Lu P; Zhang JY; Lin HB; Tang X; Gao P
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jun; 43(6):945-952. PubMed ID: 35725354
[No Abstract] [Full Text] [Related]
15. Performance of Risk Assessment Models for Prevalent or Undiagnosed Type 2 Diabetes Mellitus in a Multi-Ethnic Population-The Helius Study.
Obura MO; van Valkengoed IG; Rutters F; 't Hart LM; Rauh SP; Moll van Charante EP; Snijder MB; Beulens JWJ
Glob Heart; 2021 Feb; 16(1):13. PubMed ID: 33598393
[TBL] [Abstract][Full Text] [Related]
16. Machine Learning for Predicting the 3-Year Risk of Incident Diabetes in Chinese Adults.
Wu Y; Hu H; Cai J; Chen R; Zuo X; Cheng H; Yan D
Front Public Health; 2021; 9():626331. PubMed ID: 34268283
[No Abstract] [Full Text] [Related]
17. A prediction model for type 2 diabetes risk among Chinese people.
Chien K; Cai T; Hsu H; Su T; Chang W; Chen M; Lee Y; Hu FB
Diabetologia; 2009 Mar; 52(3):443-50. PubMed ID: 19057891
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and Genetic Markers Improve Prediction of Incident Type 2 Diabetes: A Nested Case-Control Study in Chinese.
Liu J; Wang L; Qian Y; Shen Q; Yang M; Dong Y; Chen H; Yang Z; Liu Y; Cui X; Ma H; Jin G
J Clin Endocrinol Metab; 2022 Nov; 107(11):3120-3127. PubMed ID: 35977051
[TBL] [Abstract][Full Text] [Related]
19. German Diabetes Risk Score for the Determination of the Individual Type 2 Diabetes Risk.
Schiborn C; Paprott R; Heidemann C; Kühn T; Fritsche A; Kaaks R; Schulze MB
Dtsch Arztebl Int; 2022 Sep; 119(39):651-657. PubMed ID: 35915922
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
